Patents by Inventor Marcos García Fuentes

Marcos García Fuentes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200129575
    Abstract: The present invention relates to a purified pollen particle that retains its intine and of exine layer and comprises nanosystems, to compositions including same, and to uses thereof.
    Type: Application
    Filed: February 8, 2018
    Publication date: April 30, 2020
    Inventors: Noemi CSABA, Diego PAN DELGADO, Sonia REIMONDEZ TROITIÑO, Marcos GARCÍA FUENTES
  • Patent number: 9415019
    Abstract: The invention relates to a system for administering active ingredients, including nanocapsules comprising an oil, a cationic surfactant and a polymer selected from the group consisting of polyglutamic acid (PGA), polyglutamic-polyethyleneglycol acid (PGA-PEG), hyaluronic acid (HA) and polyasparagine (PAsn) or a combination of same and, optionally, an active ingredient, with the condition that when the polymer includes polyglutamic acid or polyglutamic-polyethyleneglycol acid (PGA-PEG) the active ingredient is not a didemnin or a tamandarin. The invention also relates to methods for obtaining said nanocapsule system, the pharmaceutical compositions thereof and the use of same in medicine.
    Type: Grant
    Filed: January 9, 2012
    Date of Patent: August 16, 2016
    Assignee: Universidade de Santiago de Compostela
    Inventors: María José Alonso Fernández, Dolores Torres Lopez, Gustavo Rivera Rodriguez, Felipe Andrés Oyarzún Ampuero, Giovanna Lollo, Teresa Gonzalo Lázaro, Marcos García Fuentes
  • Publication number: 20140023703
    Abstract: The invention relates to a system for administering active ingredients, including nanocapsules comprising an oil, a cationic surfactant and a polymer selected from the group consisting of polyglutamic acid (PGA), polyglutamic-polyethyleneglycol acid (PGA-PEG), hyaluronic acid (HA) and polyasparagine (PAsn) or a combination of same and, optionally, an active ingredient, with the condition that when the polymer includes polyglutamic acid or polyglutamic-polyethyleneglycol acid (PGA-PEG) the active ingredient is not a didemnin or a tamandarin. The invention also relates to methods for obtaining said nanocapsule system, the pharmaceutical compositions thereof and the use of same in medicine.
    Type: Application
    Filed: January 9, 2012
    Publication date: January 23, 2014
    Applicant: Universidade de Santiago de Compostela
    Inventors: María José Alonso Fernández, Dolores Torres Lopez, Gustavo Rivera Rodriguez, Felipe Andrés Oyarzún Ampuero, Giovanna Lollo, Teresa Gonzalo Lázaro, Marcos Garcia Fuentes
  • Publication number: 20080220030
    Abstract: This invention relates to a system comprising nanoparticles designed for the release of biologically active molecules, where the nanoparticles comprise a) at least 40% by weight of chitosan or a derivative thereof and b) less than 60% by weight of a cyclodextrin or a derivative thereof, where both components a) and b) are mixed, without any covalent bond between them. This system allows for the efficient association of biologically active molecules, as well as their subsequent release in a suitable biological environment.
    Type: Application
    Filed: June 1, 2006
    Publication date: September 11, 2008
    Applicant: UNIVERSIDADE DE SANTIAGO DE COMPOSTELA
    Inventors: Ma Jose Alonso Fernandez, Marcos Garcia Fuentes, Francesca Maestrelli, Paola Mura